Precision BioSciences, Inc., has announced its latest program updates across its allogeneic CAR T pipeline.

To help molecular diagnostic manufacturers and clinical testing laboratories adapt to higher-standard In Vitro Diagnostic Requirements (IVDR) now in effect in the European Union, Thermo Fisher Scientific is offering an IVDR version of the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System globally.

AMSBIO announce a new range of high-quality bispecific antibodies (BsAbs) and trispecific antibodies (TsAbs) that can used to provide enhanced cancer therapeutic efficacy and/or safety compared to what can be achieved with conventional monospecific antibodies.

AMSBIO offer an extensive range of aptamers targeting many human proteins linked to cancer.

Under the expanded collaboration, Proteros will receive additional research funding, milestone payments plus royalties.

Maxwell™ Preclinical MRI Magnets do not require liquid helium, facilitating siting.

Bio-Rad Laboratories, Inc. has introduced a range of antibodies that are specific to cemiplimab (Libtayo) and inhibit the binding of the drug to its target, human programmed death receptor-1 (PD-1).

A new diagnostic test for lung cancer could identify high-risk patients even before the onset of symptoms.

Personalis has announced the issuance of a key US Patent related to its industry-leading minimal residual disease (MRD) and recurrence platform, NeXT Personal.

BioChromato Inc reports how the renowned Chemistry Research Laboratories (CRL) at Oxford University (UK) are using several Smart Evaporator C1 units to support their drug discovery activities in therapeutic areas including oncology and regenerative medicine.